ATHENS, may 18 — RIA Novosti. Novosibirsk scientists suggest a new technology of mass testing for the coronavirus that causes the exhalation with the help of Russian gas analyzer, said on Monday inter-Ministerial group under the Siberian branch of the RAS against COVID-19.

the message explains that the breath of man is a complex mixture of about 750 volatile compounds, the so-called “metabolic fingerprint”. Analysis of human breath allows non-invasive control of biochemical processes, which makes the procedure accessible and safe. To date, the use of big exhalation of a person is limited to due the high cost of special and high-precision instruments.

“At the Institute of automation and Electrometry SB RAS jointly with an industrial partner, the company “Syntopicon”, created by local gas analyzer HealthMonitor, allowing to overcome the existing technological barrier for the transition methodology in mass use. Compact domestic gas detector is produced on the territory of Novosibirsk Akademgorodok and operated in 12 countries”, — stated in the message.

In connection with the need for a participatory diagnosis of the coronavirus at the stage of the incubation period, scientists have proposed a solution for the diagnosis of people in the crowded areas and the long stay (airports, railway stations, subway, shops, pharmacies), in workplaces and in other cases.

“the Primary diagnosis for metabolic fingerprints holds the neural network. In order to teach it at an accelerated rate, the head of the interdepartmental group at the SB RAS, COVID-19 academician Mikhail Ivanovich, the Governor appealed to the mayor of Moscow Sergei Sobyanin, as scientists need to assemble a collection of materials of the patients with coronavirus infection and pneumonia to identify relevant biomarkers (the results of the metabolism occurring in the body in response to infection COVID-19)”, — stated in the message.

the Latest data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.